Men Are Vulnerable to Breast Cancer Too
October 26, 2021
In recent years, incidences of male breast cancer have increased. According to the Centers for Disease Control and Prevention (CDC), about one out of every 100 breast (Read More)
Breast Cancer Screening Awareness Is Always Essential
October 21, 2021
While Breast Cancer Awareness Month is an excellent way to bring attention to this type of cancer, my OHC colleagues and I urge women to remain up to date on screening guidelines throughout the year. OHC recently posted updated cancer screening (Read More)
Physical Activity May Limit the Effects of "Chemobrain"
October 20, 2021
Many of us have failed to place a name with a familiar face, struggled to concentrate during a long lecture, or misplaced the car keys, but for cancer patients undergoing treatment, this cognitive impairment can happen all too frequently and (Read More)
OHC Cancer Specialist Closes the Palliative Care Knowledge Gap
October 11, 2021
A recent study conducted by researchers at the University of Oklahoma Health Sciences Center revealed that nearly 90% of American adults have inadequate knowledge of palliative care. Why is there a tremendous knowledge gap about a healthcare (Read More)
Like 90% of women who receive a normal mammogram result each year, Cheryl Wilde breathed a huge sigh of relief when she was told her results were clear. Yet, although she received what she thought was excellent news that day in 1994, her breast (Read More)
Next-Generation Sequencing: A Valuable Tool in Creating a Personalized Treatment Plan for Cancer Patients
October 4, 2021
The 2017 FDA approval of Keytruda for patients whose cancers have specific genetic features was the first time the agency approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor began to grow. (Read More)
Attentive and Expedient Care of OHC Cancer Specialists Has a Lasting Impression on an Ovarian Cancer Survivor
September 30, 2021
Ovarian cancer awareness remains on the forefront of the minds of OHC’s cancer specialists. Ovarian cancer is most often diagnosed in its late stages as its presenting symptoms are typically subtle and (Read More)
OHC Clinical Trial Impacts FDA Approval of Promising Therapy for Aggressive Breast Cancer
September 28, 2021
With an enduring interest in offering hope to patients with aggressive cancers, OHC participated in a clinical trial that recently resulted in the FDA approval of a new (Read More)
OHC Ovarian Cancer Survivor: Your Attitude Impacts Your Healing
September 21, 2021
Imagine going to the doctor with some abdominal pain. You’re not expecting the worst. Appendicitis and a hernia are ruled out and a blood test and chest X-ray are ordered. Upon receiving additional test results, your doctor immediately admits (Read More)
OHC's Research Influences the FDA Approval of Another Cancer Therapy
September 1, 2021
In its relentless pursuit of the newest and most innovative cancer treatments, OHC has recently played a role in three new FDA approved therapies. On August 10, the FDA approved Lenvima (lenvatnib) plus Keytruda (pembrolizumab) for adults with (Read More)
Members of the OHC Community Honored as Unsung Heroes
August 30, 2021
Last week, Cancer Family Care (CFC) hosted its 19th annual Joslin Haggart Yeiser Unsung Hero Awards to honor patients, caregivers, and oncology professionals who quietly change the lives of those living with cancer. The event recognized 2020 (Read More)
When David Shellabarger went to his doctor because he was experiencing stomach pain, he didn’t expect a cancer diagnosis. “I thought I had a hernia,” said David. “My CT scan and biopsy revealed (Read More)